These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 26285242)

  • 1. On the Verge: Immunotherapy for Colorectal Carcinoma.
    Oh DY; Venook AP; Fong L
    J Natl Compr Canc Netw; 2015 Aug; 13(8):970-8. PubMed ID: 26285242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Expanding Role for Immunotherapy in Colorectal Cancer.
    Bever KM; Le DT
    J Natl Compr Canc Netw; 2017 Mar; 15(3):401-410. PubMed ID: 28275038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunotherapy in colorectal cancer: rationale, challenges and potential.
    Ganesh K; Stadler ZK; Cercek A; Mendelsohn RB; Shia J; Segal NH; Diaz LA
    Nat Rev Gastroenterol Hepatol; 2019 Jun; 16(6):361-375. PubMed ID: 30886395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is There a Role for Programmed Death Ligand-1 Testing and Immunotherapy in Colorectal Cancer With Microsatellite Instability? Part I-Colorectal Cancer: Microsatellite Instability, Testing, and Clinical Implications.
    Marginean EC; Melosky B
    Arch Pathol Lab Med; 2018 Jan; 142(1):17-25. PubMed ID: 29144791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Potential Value of Immunotherapy in Colorectal Cancers: Review of the Evidence for Programmed Death-1 Inhibitor Therapy.
    Toh JWT; de Souza P; Lim SH; Singh P; Chua W; Ng W; Spring KJ
    Clin Colorectal Cancer; 2016 Dec; 15(4):285-291. PubMed ID: 27553906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunomodulation in colorectal cancer: disappointment or promise?
    Pentheroudakis G; Pavlidis N
    Ann Oncol; 2003 Mar; 14(3):349-51. PubMed ID: 12598336
    [No Abstract]   [Full Text] [Related]  

  • 7. Colorectal cancer vaccines: Tumor-associated antigens
    Wagner S; Mullins CS; Linnebacher M
    World J Gastroenterol; 2018 Dec; 24(48):5418-5432. PubMed ID: 30622371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The potential role of immunotherapy to treat colorectal cancer.
    Amin M; Lockhart AC
    Expert Opin Investig Drugs; 2015 Mar; 24(3):329-44. PubMed ID: 25519074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunotherapy for colorectal cancer].
    Tougeron D; Fauquembergue É; Latouche JB
    Bull Cancer; 2013 Sep; 100(9):871-85. PubMed ID: 23917703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Testing for the Treatment of Advanced Colorectal Cancer: An Overview.
    Lin PS; Semrad TJ
    Methods Mol Biol; 2018; 1765():281-297. PubMed ID: 29589315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Developments in immunotherapy for gastrointestinal cancer.
    Diaz JL; Wanta SM; Fishbein TM; Kroemer A
    Minerva Chir; 2015 Aug; 70(4):217-30. PubMed ID: 25916195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotherapy regimens for metastatic colorectal carcinomas.
    Bashir B; Snook AE
    Hum Vaccin Immunother; 2018 Feb; 14(2):250-254. PubMed ID: 29083978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [MSI Status in Colorectal Cancer].
    Mishima S; Yoshino T
    Gan To Kagaku Ryoho; 2018 Nov; 45(11):1567-1572. PubMed ID: 30449839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotherapy for colorectal cancer.
    Koido S; Ohkusa T; Homma S; Namiki Y; Takakura K; Saito K; Ito Z; Kobayashi H; Kajihara M; Uchiyama K; Arihiro S; Arakawa H; Okamoto M; Gong J; Tajiri H
    World J Gastroenterol; 2013 Dec; 19(46):8531-42. PubMed ID: 24379570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results and challenges of immune checkpoint inhibitors in colorectal cancer.
    Emambux S; Tachon G; Junca A; Tougeron D
    Expert Opin Biol Ther; 2018 May; 18(5):561-573. PubMed ID: 29471676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of transmembrane glycoprotein mucin 1 (MUC1) in various types of colorectal cancer and therapies: Current research status and updates.
    Guo M; You C; Dou J
    Biomed Pharmacother; 2018 Nov; 107():1318-1325. PubMed ID: 30257347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The colorectal cancer immune microenvironment and approach to immunotherapies.
    Koi M; Carethers JM
    Future Oncol; 2017 Aug; 13(18):1633-1647. PubMed ID: 28829193
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunological and biochemical modulation in the treatment of advanced colorectal cancer: update and future directions.
    Hilgenfeld RU; Kreuser ED
    Curr Top Microbiol Immunol; 1996; 213 ( Pt 3)():217-40. PubMed ID: 8815007
    [No Abstract]   [Full Text] [Related]  

  • 19. Current advancements and future perspectives of immunotherapy in colorectal cancer research.
    Kishore C; Bhadra P
    Eur J Pharmacol; 2021 Feb; 893():173819. PubMed ID: 33347822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunotherapy in human colorectal cancer: Challenges and prospective.
    Sun X; Suo J; Yan J
    World J Gastroenterol; 2016 Jul; 22(28):6362-72. PubMed ID: 27605872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.